Cover Image
市場調查報告書

醫療用微流體的全球市場:2016∼2020年

Global Microfluidic Market for Healthcare Application 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 364942
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
醫療用微流體的全球市場:2016∼2020年 Global Microfluidic Market for Healthcare Application 2016-2020
出版日期: 2016年07月21日 內容資訊: 英文 58 Pages
簡介

微流體技術,有處理少量流體的能力,有助於研究開發微尺寸的設備。還有監測患者的健康情形,確實早期發現和治療疾病。微流體設備的優點,有其緊湊尺寸,低電力消耗,成本效率,變動性高等。全球醫療用微流體市場,預計2016∼2020年以CA17.59%擴大。

本報告提供全球醫療用微流體市場相關調查,市場成長預測,各地區趨勢,市場趨勢與課題,主要供應商的競爭趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 技術環境

  • 微流體系統

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 醫療用微流體的全球市場:各用途市場分類

  • 終端用戶用途
  • 使用了微流體的體外診斷
  • 使用了微流體的醫藥品研究
  • 使用了微流體的藥物輸送設備

第8章 醫療用微流體的全球市場:各地區分類

  • 地區分類
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 醫療用微流體的全球市場:促進要素

  • 緊湊尺寸
  • 文明病的增加
  • 研究費的增加和政府的參與計劃
  • 老年人的迅速增加和年齡相關疾病的增加
  • 處理量高和反應成本的降低

第10章 促進要素的影響

第11章 醫療用微流體的全球市場:課題

  • 傳統的醫療設備的高普及率
  • 微流體價值鏈中企業的低報酬率
  • 對微流體的認識不足
  • 可靠性問題

第12章 促進要素與課題的影響

第13章 醫療用微流體的全球市場:趨勢

第14章 供應商環境

  • 競爭模式

第15章 主要供應商

  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare
  • 其他值得注意的供應商

第16章 對供應商及投資者的建議

第17章 附錄

第18章 關於Technavio

目錄
Product Code: IRTNTR8681

About Microfluidics technology

Microfluidics technology deals with the research and development of micro-scale devices, which are capable of handling small amounts of fluids. These devices are used in the healthcare sector to dispense the exact volume of fluids for research, drug development, and drug delivery. Microfluidic devices can also be used to monitor patient health status, ensuring early detection and treatment of diseases. The advantages of these devices are their compact size, low power consumption, cost efficiency, and high functionality.

Technavio's analysts forecast the global microfluidic market for healthcare application to grow at a CAGR of 17.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global microfluidic market for healthcare application for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of microfluidic devices and technology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Microfluidic Market for Healthcare Application 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson and Company
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare GmbH

Other Prominent Vendors

  • Biocartis
  • Biofluidix
  • Cepheid
  • Danaher
  • Fluidigm
  • Great Basin
  • Life Technologies
  • Oxford Nanopore
  • PerkinElmer
  • Tear Lab
  • Thermo Fisher Scientific

Market driver

  • Rapid increase in elderly population and age-related diseases
  • For a full, detailed list, view our report

Market challenge

  • Low margins for companies in the microfluidic value chain
  • For a full, detailed list, view our report

Market trend

  • Use of paper-based microfluidic devices
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Report overview
  • Key vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Technology landscape

  • Microfluidic systems

PART 06: Market landscape

  • Industry overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by application

  • End-user applications of microfluidics in healthcare 2015
  • End-user applications of microfluidics in healthcare 2020
  • In-vitro diagnostics using microfluidics
  • Pharmaceutical research using microfluidics
  • Drug delivery devices using microfluidics

PART 08: Geographical segmentation

  • Regional segregation 2015
  • Regional segregation 2020
  • Americas
  • EMEA
  • APAC

PART 09: Market drivers

  • Compact size of microfluidic devices
  • Growth in lifestyle diseases
  • Increase in research funding and government participation
  • Rapid increase in elderly population and age-related diseases
  • Higher throughput and reduced reaction cost

PART 10: Impact of drivers

PART 11: Market challenges

  • High penetration of traditional healthcare equipment
  • Low margins for companies in the microfluidic value chain
  • Lack of awareness about microfluidics
  • Reliability issues

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Use of paper-based microfluidic devices
  • Growth in POC testing

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendors

  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare
  • Other prominent vendors

PART 16: Key recommendations for vendors and investors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Steps of a typical microfluidic process
  • Exhibit 03: Market segmentation of microfluidics in healthcare
  • Exhibit 04: Global microfluidic market for healthcare application 2016-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Percentage segregation of microfluidics for application in healthcare sector 2015
  • Exhibit 07: Percentage segregation of microfluidics for application in healthcare sector 2020
  • Exhibit 08: Global microfluidic market for in-vitro diagnostics in healthcare 2015-2020 ($ billions)
  • Exhibit 09: Global microfluidic market in pharmaceutical research for healthcare 2015-2020 ($ billions)
  • Exhibit 10: Global microfluidic market in drug delivery devices for healthcare 2015-2020 ($ millions)
  • Exhibit 11: Geographical share in percentage 2015
  • Exhibit 12: Geographical share in percentage 2020
  • Exhibit 13: Global microfluidic market for healthcare application in Americas 2016-2020 ($ billions)
  • Exhibit 14: Global microfluidic market for healthcare application in EMEA 2015-2020 ($ billions)
  • Exhibit 15: Global microfluidic market for healthcare application in APAC 2015-2020 ($ millions)
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: Overview of major players in the global microfluidic market for healthcare application 2015
  • Exhibit 19: Recent developments: Abbott Laboratories
  • Exhibit 20: Sector performance
  • Exhibit 21: Capital expenditure
  • Exhibit 22: Segment performance
  • Exhibit 23: Capital expenditure
  • Exhibit 24: Siemens Healthcare: Business segmentation
  • Exhibit 25: Recent developments: Siemens Healthcare
  • Exhibit 26: Other prominent vendors
Back to Top